S1 Biopharma CEO Nick Sitchon to Participate in Maxim Group LLC Review of Late Stage Innovations in Women’s Health

Sitchon to highlight S1 Biopharma focus on central nervous system role in issues associated with sexual function and sexual wellness. NEW YORK, March 2, 2021 /PRNewswire/ — S1 Biopharma, Inc. (S1), a clinical stage company advancing therapies based on central…